Abstract:
Diseases accompanied by broncho-obstructive syndrome, in particular bronchial asthma (BA) and chronic obstructive pulmonary disease (COPD), are significant factors that affect the quality of life and functionality of patients. The effectiveness of the therapy of these pathologies depends on the optimal selection of drugs, the adequacy of dosage and the possibility of reducing the financial burden for both patients and the health care system. Modern pharmacoepidemiology provides opportunities for evaluating the effectiveness and economic feasibility of treatment regimens, which allows determining optimal approaches to therapy. However, there is insufficient data on the effectiveness of various treatment regimens for asthma and COPD in local medical institutions, which limits the possibilities of adapting international protocols to the conditions of real clinical practice. The purpose of this study was to conduct a comparative analysis of the effectiveness and cost-effectiveness of three regimens for the treatment of broncho-obstructive diseases in patients of the MNCE "Haysynska CDH of HCC".
